Detalhe da pesquisa
1.
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 555-564, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230585
2.
A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
Breast Cancer Res Treat
; 187(3): 777-784, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740205
3.
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Lancet
; 394(10215): 2155-2164, 2019 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813636
4.
The ongoing evaluation and evolution of breast cancer surgical care.
Breast J
; 26(3): 494-497, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493300
5.
Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.
Support Care Cancer
; 27(2): 495-503, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29980907
6.
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Breast Cancer Res Treat
; 168(1): 69-77, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29128898
7.
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).
Ann Surg
; 266(4): 667-676, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28657941
8.
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 849-56, 2016 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686957
9.
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 857-65, 2016 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686960
10.
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 565, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507135
11.
Landmark clinical trials influencing surgical management of non-invasive and invasive breast cancer.
Breast J
; 21(1): 60-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25521007
12.
Effect of occult metastases on survival in node-negative breast cancer.
N Engl J Med
; 364(5): 412-21, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21247310
13.
Shortened radiation therapy schedules for early-stage breast cancer: a review of hypofractionated whole-breast irradiation and accelerated partial breast irradiation.
Breast J
; 20(2): 131-46, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24479632
14.
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Breast Cancer Res Treat
; 142(2): 415-21, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24202240
15.
Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.
J Support Oncol
; 11(1): 22-30, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22951047
16.
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
JAMA
; 310(14): 1455-61, 2013 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101169
17.
Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study.
JMIR Cancer
; 8(3): e38514, 2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006678
18.
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
J Clin Oncol
; 40(9): 978-987, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995128
19.
The need for axillary dissection in patients with positive axillary sentinel lymph nodes.
Curr Oncol Rep
; 13(1): 5-10, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20957459
20.
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Lancet Oncol
; 11(10): 927-33, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20863759